300 episodes

Cardionerds is a medical cardiology podcast created to bring high yield cardiovascular concepts in a fun and engaging format for listeners of all levels.



We aim to democratize cardiovascular education, promote diversity & inclusion in our beloved field, empower every learner to teach & every teacher to learn and foster wellness & humanity for all.



Check us out! www.cardionerds.com

Cardionerds: A Cardiology Podcast CardioNerds

    • Health & Fitness
    • 5.0 • 11 Ratings

Cardionerds is a medical cardiology podcast created to bring high yield cardiovascular concepts in a fun and engaging format for listeners of all levels.



We aim to democratize cardiovascular education, promote diversity & inclusion in our beloved field, empower every learner to teach & every teacher to learn and foster wellness & humanity for all.



Check us out! www.cardionerds.com

    364. Case Report: A Drug’s Adverse Effect Unleashes the Wolf – Beth Israel Deaconess Medical Center

    364. Case Report: A Drug’s Adverse Effect Unleashes the Wolf – Beth Israel Deaconess Medical Center

    CardioNerds join Dr. Inbar Raber and Dr. Susan Mcilvaine from the Beth Israel Deaconess Medical Center for a Fenway game. They discuss the following case: A 72-year-old man presents with two weeks of progressive dyspnea, orthopnea, nausea, vomiting, diarrhea, and right upper quadrant pain. He has a history of essential thrombocytosis, Barrett’s esophagus, basal cell skin cancer, and hypertension treated with hydralazine. He is found to have bilateral pleural effusions and a pericardial effusion. He undergoes a work-up, including pericardial cytology, which is negative, and blood tests reveal a positive ANA and positive anti-histone antibody. He is diagnosed with drug-induced lupus due to hydralazine and starts treatment with intravenous steroids, resulting in an improvement in his symptoms. Expert commentary is provided by UT Southwestern internal medicine residency program director Dr. Salahuddin (“Dino”) Kazi.















    US Cardiology Review is now the official journal of CardioNerds! Submit your manuscript here.



















    CardioNerds Case Reports PageCardioNerds Episode PageCardioNerds AcademyCardionerds Healy Honor Roll











    CardioNerds Journal ClubSubscribe to The Heartbeat Newsletter!Check out CardioNerds SWAG!Become a CardioNerds Patron!











    Case Media



























    Pearls - A Drug's Adverse Effect Unleashes the Wolf









    * The differential diagnosis for pericardial effusion includes metabolic, malignant, medication-induced, traumatic, rheumatologic, and infectious etiologies.







    * While pericardial cytology can aid in securing a diagnosis of cancer in patients with malignant pericardial effusions, the sensitivity of the test is limited at around 50%. 







    * Common symptoms of drug-induced lupus include fever, arthralgias, myalgias, rash, and/or serositis.







    * Anti-histone antibodies are typically present in drug-induced lupus, while anti-dsDNA antibodies are typically absent (unlike in systemic lupus erythematosus, SLE).







    * Hydralazine-induced lupus has a prevalence of 5-10%, with a higher risk for patients on higher doses or longer durations of drug exposure. Onset is usually months to years after drug initiation.









    Show Notes - A Drug's Adverse Effect Unleashes the Wolf









    * There is a broad differential diagnosis for pericardial effusion which includes metabolic, malignant, medication-induced, traumatic, rheumatologic, and infectious etiologies.

    • 38 min
    363. GLP-1 Agonists: Diving into the Data with Dr. Darren McGuire

    363. GLP-1 Agonists: Diving into the Data with Dr. Darren McGuire

    Welcome back to the CardioNerds Cardiovascular Prevention Series, where we are continuing our discussion of Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs). This class of medications is becoming a household name, not only for their implications for weight loss but also for their effect on cardiovascular disease. CardioNerds Dr. Ty Sweeney (CardioNerds Academy Faculty Member and incoming Cardiology Fellow at Boston Medical Center), Dr. Rick Ferraro (CardioNerds Academy House Faculty and Cardiology Fellow at Johns Hopkins Hospital), and special guest Dr. Franck Azobou (Cardiology Fellow at UT Southwestern) sat down with Dr. Darren McGuire (Cardiologist at UT Southwestern and Senior Editor of Diabetes and Vascular Disease Research) to discuss important trial data on GLP-1 RAs in patients with heart disease, as well as recent professional society guidelines on their use. Show notes were drafted by Dr. Ty Sweeney. Audio editing was performed by CardioNerds Intern student Dr. Diane Masket.







    If you haven’t already, be sure to check out CardioNerds episode #350 where we discuss the basics and mechanism of action of GLP-1 RAs with Dr. Dennis Bruemmer.















    This episode was produced in collaboration with the American Society of Preventive Cardiology (ASPC) with independent medical education grant support from Novo Nordisk. See below for continuing medical education credit.







    Claim CME for this episode HERE.























    CardioNerds Prevention PageCardioNerds Episode PageCardioNerds AcademyCardionerds Healy Honor Roll











    CardioNerds Journal ClubSubscribe to The Heartbeat Newsletter!Check out CardioNerds SWAG!Become a CardioNerds Patron!



















    Pearls and Quotes - GLP-1 Agonists: Diving into the Data









    * Patients with diabetes and clinical atherosclerotic cardiovascular disease (ASCVD) or who are at high risk of ASCVD benefit from treatment with a GLP-1 RA.







    * For persons with sufficient ASCVD risk and type 2 diabetes, GLP-1 RAs and SGLT2 inhibitors can, and often should, be used in combination. "Just like we don’t consider ‘and/or’ for the four pillars of guideline-directed medical therapy for heart failure with reduced ejection fraction, we shouldn’t parcel out these two therapeutic options...it should be both.”







    * Setting expectations with your patients regarding injection practices, side effects, and expected benefits can go a long way toward improving the ...

    • 43 min
    362. Guidelines: 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure – Question #32 with Dr. Harriette Van Spall

    362. Guidelines: 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure – Question #32 with Dr. Harriette Van Spall

    The following question refers to Section 13 of the 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure.The question is asked by Western Michigan University medical student and CardioNerds Intern Shivani Reddy, answered first by Mayo Clinic Cardiology Fellow and CardioNerds Academy Faculty Dr. Dinu Balanescu, and then by expert faculty Dr. Harriette Van Spall.Dr. Van Spall is an Associate Professor of Medicine, cardiologist, and Director of E-Health at McMaster University. Dr Van Spall is a Canadian Institutes of Health Research-funded clinical trialist and researcher with a focus on heart failure, health services, and health disparities.The Decipher the Guidelines: 2022 AHA / ACC / HFSA Guideline for The Management of Heart Failure series was developed by the CardioNerds and created in collaboration with the American Heart Association and the Heart Failure Society of America. It was created by 30 trainees spanning college through advanced fellowship under the leadership of CardioNerds Cofounders Dr. Amit Goyal and Dr. Dan Ambinder, with mentorship from Dr. Anu Lala, Dr. Robert Mentz, and Dr. Nancy Sweitzer. We thank Dr. Judy Bezanson and Dr. Elliott Antman for tremendous guidance.Enjoy this Circulation 2022 Paths to Discovery article to learn about the CardioNerds story, mission, and values.





    Question #32









    Palliative and supportive care has a role for patients with heart failure only in the end stages of their disease.









    TRUE









    FALSE













    Answer #32









    Explanation





    The correct answer is False

    Palliative care is patient- and family-centered care that optimizes health-related quality of life by anticipating, preventing,

    • 17 min
    361. Case Report: Sore Throat, Fever, and Myocarditis – It’s not always COVID-19! – University of Maryland

    361. Case Report: Sore Throat, Fever, and Myocarditis – It’s not always COVID-19! – University of Maryland

    CardioNerds cofounder Dr. Dan Ambinder joins Dr. Angie Molina, Dr. Cullen Soares, and Dr. Andrew Lutz from the University of Maryland Medical Center for some beers and history by Fort McHenry. They discuss a case of disseminated haemophilus influenzapresumed fulminant bacterial myocarditis with mixed septic/cardiogenic shock. Expert commentary is provided by Dr. Stanley Liu (Assistant Professor, Division of Cardiovascular Medicine, University of Maryland School of Medicine). Episode audio was edited by Dr. Chelsea Amo-Tweneboah.







    A woman in her twenties with a history of intravenous drug use presented with acute onset fevers and sore throat, subsequently developed respiratory distress and cardiac arrest, and was noted to have epiglottic edema on intubation. She developed shock and multiorgan failure. ECG showed diffuse ST elevations, TTE revealed biventricular dysfunction, and pleural fluid culture grew Haemophilus influenza. Right heart catheterization showed evidence of cardiogenic shock. She improved with supportive care and antibiotics.















    US Cardiology Review is now the official journal of CardioNerds! Submit your manuscript here.



















    CardioNerds Case Reports PageCardioNerds Episode PageCardioNerds AcademyCardionerds Healy Honor Roll











    CardioNerds Journal ClubSubscribe to The Heartbeat Newsletter!Check out CardioNerds SWAG!Become a CardioNerds Patron!











    Pearls - Sore Throat, Fever, and Myocarditis - It’s not always COVID-19









    * The post-cardiac arrest ECG provides helpful information for diagnosing the underlying etiology.​







    * Be aware of diagnostic biases - availability and anchoring biases are particularly common during respiratory viral (such as COVID-19, RSV) surges.







    * Consider a broad differential diagnosis in evaluating myocarditis, including non-viral etiologies.







    * Right heart catheterization provides crucial information for diagnosis and management of undifferentiated shock​.







    * When assessing the need for mechanical circulatory support, consider the current hemodynamics, type of support needed,

    • 41 min
    360. Obesity: Lifestyle & Pharmacologic Management of Obesity with Dr. Ambarish Pandey

    360. Obesity: Lifestyle & Pharmacologic Management of Obesity with Dr. Ambarish Pandey

    CardioNerds Dr. Rick Ferraro (CardioNerds Academy House Faculty and Cardiology Fellow at JHH), Dr. Gurleen Kaur (Director of the CardioNerds Internship and Internal Medicine resident at BWH), and Dr. Alli Bigeh (Cardiology Fellow at the Ohio State) as they discuss the growing obesity epidemic and how it relates to cardiovascular disease with Dr. Ambarish Pandey (Cardiologist at UT Southwestern Medical Center). Show notes were drafted by Dr. Alli Bigeh. CardioNerds Academy Intern and student Dr. Shivani Reddy performed audio editing.







    Obesity is an important modifiable risk factor for cardiovascular disease, and it is on the rise! Here, we discuss how to identify patients with obesity and develop an approach to address current lifestyle recommendations. We also discuss the spectrum of pharmacologic treatment options available, management strategies, and some therapy options that are on the horizon.







    This episode was produced in collaboration with the American Society of Preventive Cardiology (ASPC) with independent medical education grant support from Novo Nordisk. See below for continuing medical education credit.







    Claim CME for this episode HERE.























    CardioNerds Prevention PageCardioNerds Episode PageCardioNerds AcademyCardionerds Healy Honor Roll











    CardioNerds Journal ClubSubscribe to The Heartbeat Newsletter!Check out CardioNerds SWAG!Become a CardioNerds Patron!



















    Pearls and Quotes - Lifestyle & Pharmacologic Management of Obesity









    * Identify obese patients not just using BMI, but also using anthropometric measurements such as waist circumference (central adiposity).







    * Lifestyle modifications are our first line of defense against obesity! Current recommendations emphasize caloric restriction of at least 500kcal/day, plant-based and Mediterranean diets, and getting at least 150 minutes of moderate-intensity weekly exercise.







    * Dive into the root cause of eating and lifestyle behaviors. It is crucial to address adverse social determinants of health with patients to identify the driving behaviors, particularly among those individuals of low socioeconomic status.







    * Newer weight loss agents are most effective at achieving and maintaining substantial weight loss, in particular Semaglutide (GLP-1) and Tirzepatide (GLP-1/GIP).

    359. Case Report: Fee-Fi-Fo-Fum: An Unusual Case of Rapidly Progressive Heart Failure – Georgetown University

    359. Case Report: Fee-Fi-Fo-Fum: An Unusual Case of Rapidly Progressive Heart Failure – Georgetown University

    CardioNerds join Dr. Ethan Fraser and Dr. Austin Culver from the MedStar Georgetown University Hospital internal medicine and cardiology programs in our nation’s capital. They discuss the following case involving an unusual case of rapidly progressive heart failure. Episode audio was edited by CardioNerds Academy Intern and student Dr. Pacey Wetstein. Expert commentary was provided by advanced heart failure cardiologist Dr. Richa Gupta.







    A 55-year-old male comes to the clinic (and eventually into the hospital) for what appears to be a straightforward decompensation of his underlying cardiac disease. However, things aren’t as simple as they might appear. In this episode, we will discuss the outpatient workup for non-ischemic cardiomyopathy and discuss the clinical indicators that we as clinicians should be aware of in these sick patients. Furthermore, we will discuss the differential for NICM, the management of patients with this rare disease, and how this disease can mimic other cardiomyopathies.















    US Cardiology Review is now the official journal of CardioNerds! Submit your manuscript here.



















    CardioNerds Case Reports PageCardioNerds Episode PageCardioNerds AcademyCardionerds Healy Honor Roll











    CardioNerds Journal ClubSubscribe to The Heartbeat Newsletter!Check out CardioNerds SWAG!Become a CardioNerds Patron!











    Case Media - Rapidly Progressive Heart Failure



































    Pearls - Rapidly Progressive Heart Failure









    * The non-ischemic cardiomyopathy workup should incorporate targeted multimodal imaging, thorough history taking, broad laboratory testing, genetic testing if suspicion exists for a hereditary cause, and a deep understanding of which populations are at higher risk for certain disease states.



    * Key Point: Always challenge and question the etiology of an unknown cardiomyopathy – do not assume an etiology based on history/patient story alone. 















    * Unexplained conduction disease in either a young or middle-aged individual in the setting of a known cardiomyopathy should raise suspicion for an infiltrative cardiomyopathy and set off a referral to an advanced heart failure program.



    * Key Point: Consider early/more aggressive imaging for these patients and early electrophysiology referral for primary/secondary prevention.

    • 59 min

Customer Reviews

5.0 out of 5
11 Ratings

11 Ratings

Top Podcasts In Health & Fitness

Huberman Lab
Scicomm Media
On Purpose with Jay Shetty
iHeartPodcasts
Passion Struck with John R. Miles
John R. Miles
Feel Better, Live More with Dr Rangan Chatterjee
Dr Rangan Chatterjee: GP & Author
The Habit Coach with Ashdin Doctor
IVM Podcasts
दिनभर: पूरा दिन,पूरी ख़बर (Dinbhar)
BBC Hindi Radio

You Might Also Like

This Week in Cardiology
Medscape
Core IM | Internal Medicine Podcast
Core IM Team
The Curbsiders Internal Medicine Podcast
The Curbsiders Internal Medicine Podcast
Eagle's Eye View: Your Weekly CV Update From ACC.org
American College of Cardiology
JACC Podcast
American College of Cardiology
The Clinical Problem Solvers
The Clinical Problem Solvers